nach oben

International Journal of Clinical Pharmacy

Erschienen in:

01.12.2011 | Research Article

Diabetes knowledge, medication adherence and glycemic control among patients with type 2 diabetes

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

Background Most of interventions that have attempted to improve medication adherence in type 2 diabetes have been educational; on the assumption that knowledge regarding diabetes might affect patients’ adherence to their treatment regimen. Objectives The purpose of the study was to investigate any association of knowledge and medication adherence with glycemic control in patients with type 2 diabetes mellitus. Setting The study was conducted at the Diabetes Outpatients Clinic, Hospital Pulau Penang. Methods A cross-sectional study was conducted with a convenience sample of 540 adult patients with type 2 diabetes attending the clinic. A questionnaire including previously validated Michigan Diabetes Knowledge Test and Morisky Medication Adherence Scale was used and the patients’ medical records were reviewed for haemoglobin A1C (HbA1C) levels and other disease-related information. A total of 35 (6.48%) patients were excluded after data collection due to lack of HbA1C results. Results Five hundred and five patients were included in the final analysis, with a mean age of 58.15 years (SD = 9.16), 50.7% males and median HbA1C of 7.6 (IQR was 6.7–8.9). The median total knowledge score was 7.0 (IQR was 5.0–10.0) while the median adherence score was 6.5 (IQR was 4.75–7.75). Significant correlations were found between the three variables (HbA1C, knowledge and adherence). A significantly higher score for knowledge and adherence (P < 0.05) was found in those patients with lower HbA1C. Higher diabetes knowledge, higher medication adherence and using mono-therapy were significant predictors of good glycemic control in the multivariate analysis. Conclusion Patients’ knowledge about diabetes is associated with better medication adherence and better glycemic control. In addition to other factors affecting medication adherence and glycemic control, healthcare providers should pay attention to knowledge about diabetes that the patients carry towards medication adherence.

Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–53.PubMedCrossRef

NHM I. The third national and morbidity survey. 2006 [cited 2009 July 23]; Available from: http://www.nih.gov.my/NHMS/abstracts_17.html.

Wong J, Rahimah N. Glycaemic control of diabetic patients in an urban primary health care setting in Sarawak: the Tanah Puteh health centre experience. Med J Malaysia. 2004;59(3):411–7.PubMed

Mafauzy M. Diabetes control and complications in public hospitals in Malaysia. Med J Malaysia. 2006;61(4):477–83.PubMed

Ministry of Health Malaysia. Clinical practice guidelines: management of type 2 diabetes mellitus. 2009 [cited 2010 January, 20]; Available from: http://www.moh.gov.my.

Ooyub S, Ismail F, Daud N. Diabetes program in Malaysia—current and future. NCD Malaysia. 2004;3:6–12.

Murata G, Shah J, Adam K, Wendel C, Bokhari S, Solvas P, et al. Factors affecting diabetes knowledge in type 2 diabetic veterans. Diabetologia. 2003;46(8):1170–8.PubMedCrossRef

Al Shafaee M, Al-Shukaili S, Rizvi S, Al Farsi Y, Khan M, Ganguly S, et al. Knowledge and perceptions of diabetes in a semi-urban Omani population. BMC Public Health. 2008;8(1):249.PubMedCrossRef

Bruce D, Davis W, Cull C, Davis T. Diabetes education and knowledge in patients with type 2 diabetes from the community: the Fremantle diabetes study. J Diabetes Complic. 2003;17(2):82–9.CrossRef

10.

McClean M, McElnay J, Andrews W. The association of psychosocial and diabetes factors to diabetes knowledge. Int J Pharm Pract. 2001;9:R9.CrossRef

11.

Gunay T, Ulusel B, Velipasaoglu S, Unal B, Ucku R, Ozgener N. Factors affecting adult knowledge of diabetes in Narlidere Health District, Turkey. Acta Diabetol. 2006;43(4):142–7.PubMedCrossRef

12.

Angeles-Llerenas A, Carbajal-Sánchez N, Allen B, Zamora-Muñoz S, Lazcano-Ponce E. Gender, body mass index and socio-demographic variables associated with knowledge about type 2 diabetes mellitus among 13 293 Mexican students. Acta Diabetol. 2005;42(1):36–45.PubMedCrossRef

13.

Murugesan N, Snehalatha C, Shobhana R, Roglic G, Ramachandran A. Awareness about diabetes and its complications in the general and diabetic population in a city in southern India. Diabetes Res Clin Pract. 2007;77(3):433–7.PubMedCrossRef

14.

Funnell M, Brown T, Childs B, Haas L, Hosey G, Jensen B, et al. National standards for diabetes self-management education. Diabetes Care. 2007;30(6):1630–7.PubMedCrossRef

15.

World Health Organization. Report on medication adherence: Geneva, WHO; 2003.

16.

Rhee M, Slocum W, Ziemer D, Culler S, Cook C, El-Kebbi I, et al. Patient adherence improves glycemic control. Diabetes Educ. 2005;31(2):240–50.PubMedCrossRef

17.

Simpson S, Eurich D, Majumdar S, Padwal R, Tsuyuki R, Varney J, et al. A meta-analysis of the association between adherence to drug therapy and mortality. Br Med J. 2006;333(7557):18–9.CrossRef

18.

Krapek K, King K, Warren S, George K, Caputo D, Mihelich K, et al. Medication adherence and associated hemoglobin A1c in type 2 diabetes. Ann Pharmacother. 2004;38(9):1357–62.PubMedCrossRef

19.

Briesacher B, Andrade S, Fouayzi H, Chan K. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy. 2008;28(4):437–43.PubMedCrossRef

20.

Funnell M, Anderson R. Empowerment and self-management of diabetes. Clin Diabetes. 2004;22(3):123–7.CrossRef

21.

Merican M, Rohaizat Y, Haniza S. Developing the Malaysian health system to meet the challenges of the future. Med J Malaysia. 2004;59(1):84–93.PubMed

22.

Fitzgerald J, Funnell M, Hess G, Barr P, Anderson R, Hiss R, et al. The reliability and validity of a brief diabetes knowledge test. Diabetes Care. 1998;21(5):706–10.PubMedCrossRef

23.

Al-Qazaz H, Hassali M, Shafie A, Sulaiman S, Sundram S. The 14-item Michigan diabetes knowledge test: translation and validation study of the Malaysian version. Pract Diabetes Int. 2010;27(6):238–241a.CrossRef

24.

Morisky D, Ang A, Krousel-Wood M, Ward H. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10(5):348–54.CrossRef

25.

Al-Qazaz H, Hassali M, Shafie A, Sulaiman S, Sundram S, Morisky D. The eight-item Morisky Medication Adherence Scale MMAS: translation and validation of the Malaysian version. Diabetes Res Clin Pract. 2010;90:216–21.PubMedCrossRef

26.

Krousel-Wood M, Islam T, Webber L, Re RN, Morisky D, Muntner P. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care. 2009;15(1):59–66.PubMed

27.

Sacks D, Bruns D, Goldstein D, Maclaren N, McDonald J, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem. 2002;48(3):436–72.PubMed

28.

Gonen B, Rochman H, Rubenstein A, Tanega S, Horwitz D. Haemoglobin A1: an indicator of the metabolic control of diabetic patients. Lancet. 1977;310(8041):734–7.CrossRef

29.

Hinton P, Brownlow C. SPSS explained. New York: Theatre Arts Books; 2004.

30.

Mickey R, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol. 1989;129(1):125.PubMed

31.

He X, Wharrad H. Diabetes knowledge and glycemic control among Chinese people with type 2 diabetes. Int Nurs Rev. 2007;54(3):280–7.PubMedCrossRef

32.

Tan M, Magarey J. Self-care practices of Malaysian adults with diabetes and sub-optimal glycaemic control. Patient Educ Couns. 2008;72(2):252–67.PubMedCrossRef

33.

West J, Goldberg K. Diabetes self-care knowledge among outpatients at a Veterans Affairs medical center. Am J Health Syst Pharm. 2002;59(9):849–52.PubMed

34.

Heisler M, Piette J, Spencer M, Kieffer E, Vijan S. The relationship between knowledge of recent HbA1c values and diabetes care understanding and self-management. Diabetes Care. 2005;28(4):816–22.PubMedCrossRef

35.

Al-Adsani A, Moussa M, Al-Jasem L, Abdella N, Al-Hamad N. The level and determinants of diabetes knowledge in Kuwaiti adults with type 2 diabetes. Diabetes Metab. 2009;35(2):121–8.PubMedCrossRef

36.

Lerman I. Adherence to treatment: the key for avoiding long-term complications of diabetes. Arch Med Res. 2005;36(3):300–6.PubMedCrossRef

37.

Rubin R. Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. Am J Med. 2005;118(5):27S–34S.PubMedCrossRef

38.

Bezie Y, Molina M, Hernandez N, Batista R, Niang S, Huet D. Therapeutic compliance: a prospective analysis of various factors involved in the adherence rate in type 2 diabetes. Diabetes Metab. 2006;32(6):611–6.PubMedCrossRef

39.

Ho P, Rumsfeld J, Masoudi F, McClure D, Plomondon M, Steiner J, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836–41.PubMedCrossRef

40.

Odegard P, Gray S. Barriers to medication adherence in poorly controlled diabetes mellitus. Diabetes Educ. 2008;34(4):692–7.PubMedCrossRef

41.

Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther. 2001;26(5):331–42.PubMedCrossRef

42.

Vlasnik J, Aliotta S, DeLor B. Medication adherence: factors influencing compliance with prescribed medication plans* 1. Case Manager. 2005;16(2):47–51.PubMedCrossRef

43.

Albright T, Parchman M, Burge S. Predictors of self-care behavior in adults with type 2 diabetes: an RRNeST study. Family Med. 2001;33(5):354–60.

44.

Mustaffa B, Wan Mohamad W, Chan S, Rokiah P, Mafauzy M, Kumari S, et al. The current status of diabetes management in Malaysia. JAFES. 1998;16(2):1–13.

45.

Golin C, DiMatteo M, Gelberg L. The role of patient participation in the doctor visit. Implications for adherence to diabetes care. Diabetes Care. 1996;19(10):1153–64.PubMedCrossRef

46.

Guillausseau P. Influence of oral antidiabetic drugs compliance on metabolic control in type 2 diabetes. A survey in general practice. Diabetes Metab. 2003;29(1):79–81.PubMedCrossRef

47.

Berikai P, Meyer P, Kazlauskaite R, Savoy B, Kozik K, Fogelfeld L. Gain in patients’ knowledge of diabetes management targets is associated with better glycemic control. Diabetes Care. 2007;30(6):1587–9.PubMedCrossRef

48.

Cramer J. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27(5):1218–24.PubMedCrossRef

49.

Hill-Briggs F, Gary T, Bone L, Levine D, Brancati F, Hill M. Medication adherence and diabetes control in urban African Americans with type 2 diabetes. Health Psychol. 2005;24:349–57.PubMedCrossRef

50.

Lawrence D, Ragucci K, Long L, Parris B, Helfer L. Relationship of oral antihyperglycemic (sulfonylurea or metformin) medication adherence and hemoglobin A1c goal attainment for HMO patients enrolled in a diabetes disease management program. J Manag Care Pharm. 2006;12(6):466–71.PubMed

51.

Rozenfeld Y, Hunt J, Plauschinat C, Wong K. Oral antidiabetic medication adherence and glycemic control in managed care. Am J Manag Care. 2008;14:71–5.PubMed

52.

Schectman J, Nadkarni M, Voss J. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care. 2002;25(6):1015–21.PubMedCrossRef

Titel: Diabetes knowledge, medication adherence and glycemic control among patients with type 2 diabetes
Publikationsdatum: 01.12.2011
Erschienen in: International Journal of Clinical Pharmacy / Ausgabe 6/2011
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI: https://doi.org/10.1007/s11096-011-9582-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Diabetes knowledge, medication adherence and glycemic control among patients with type 2 diabetes

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2011

A comparative pilot study of the professional ethical thinking of Quebec pharmacy residents and French pharmacy interns

Heparin-induced thrombocytopenia: comparison between response to fondaparinux and lepirudin

Clinical pharmacists and basic scientists: do patients and physicians need this collaboration?

Drug dosing and monitoring in obese patients undergoing allogenic stem cell transplantation

Evaluation of doripenem utilization and susceptibilities at a large urban hospital

Review of the cost-effectiveness of interventions to improve seamless care focusing on medication

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin